Skip to main content

Advertisement

SpringerLink
Log in

Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1]

  • Letters to the Editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hoefnagel CA, Rankin EM, Valdés Olmos RA, Israëls SP, Pavel S, Janssen AGM. Sensitivity versus specificity in melanoma imgaging using iodine-123 iodobenzamide and indium-111 pentetreotide.Eur J Nucl Med 1994; 21: 587–588

    PubMed  CAS  Google Scholar 

  2. Jensen OM, Estève J, Møller H, Renard H. Cancer in the European Community and its member states.Eur J Cancer 1990; 26: 1167–1256.

    Article  PubMed  CAS  Google Scholar 

  3. Franceschi S, La Vecchia C, Negri E, Levi F. Increases in mortality from cutaneous melanoma in southern Europe.Int J Cancer 1992; 51: 160–162.

    PubMed  CAS  Google Scholar 

  4. Geddes M, Balzi D, Tomatis L. Progress in the fight against cancer in EC countries: changes in mortality rates, 1970-90.Eur J Cancer Prev 1994; 3: 31–44.

    PubMed  CAS  Google Scholar 

  5. Buraggi GL, Callegaro L, Mariani G, et al. Imaging with131Ilabeled monoclonal antibodies to a high molecular weight melanoma associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.Cancer Res 1985; 45: 3378–3387.

    PubMed  CAS  Google Scholar 

  6. Buraggi GL, Callegaro L, Turrin A, et al. Immunoscintigraphy with123I,99mTc and111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight melanoma associated antigen.J Nucl Med Allied Sci 1984; 28: 195–283.

    Google Scholar 

  7. Siccardi AG, Buraggi GL, Natali PG, Scassellati GA, Viale G, Ferrone S. European multicenter study on melanoma immunoscintigraphy by means of99mTc-labeled monoclonal antibody fragments.Eur J Nucl Med 1990; 16: 317–323.

    Article  PubMed  CAS  Google Scholar 

  8. MaffioliL, Mascheroni L, Castellani MR, et al.123I-IBZM imaging in metastatic melanoma.J Nucl Med 1993; 34: 219P.

  9. Maffioli L, Mascheroni L, Mongioj V, et al. Scintigraphic detection of melanoma metastases with a radiolabelled benzamide ([1231])-(S)-IBZM in humans.J Nucl Med 35: (issue 1] in press)

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute Nuclear Medicine Division, Via Venezian 1 1-20133, Milan, Italy

    Lorenzo Maffioli, Arturo Chiti, Massimo Gasparini & Emilio Bombardieri

Authors
  1. Lorenzo Maffioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arturo Chiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emilio Bombardieri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maffioli, L., Chiti, A., Gasparini, M. et al. Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1]. Eur J Nucl Med 21, 1366 (1994). https://doi.org/10.1007/BF02426702

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02426702

Keywords

Search

Navigation